As part of an application to the EIC Pathfinder Open 2026 call, EU-based industrial partners are sought to support scale-up, regulatory development, and first-in-human clinical translation of innovative small-molecule modulators and targeted nanomedicine platforms. Dual-action technologies selectively influence mitochondrial and bacterial ion pathways to reprogram tumor immunity and gut microbiota, boosting the efficacy of anti-Programmed death-1 (PD-1) immunotherapy.
Jornada de Demostración Tecnológica BACSI 2026.
La UCLM estará presente en las Jornadas de Demostración Tecnológica BACSI 2026 los días 18 y 19 de marzo, mostrando su capacidad investigadora y su papel como agente clave de innovación en Castilla‑La Mancha. La universidad participará conectando a sus grupos de...
Mar 3, 2026
















